NCT02534571View on ClinicalTrials.gov

To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

September 7, 2015

Primary Completion Date

January 14, 2019

Study Completion Date

April 30, 2019

Conditions
Acute Upper Gastrointestinal Bleeding
Interventions
DEVICE

Endoscopic Application of a Hemostatic Powder TC-325

Endoscopic Application of a Hemostatic Powder TC-325 \<=150g once

DEVICE

Hemo-clipping

Hemo-clipping \<=20 clips

DRUG

Epinephrine

epinephrine injection endoscopically \<20 mls

DEVICE

thermo-coagulation

contact thermo-coagulation \< = 4 pulses

Trial Locations (1)

Unknown

Endoscopy Centre, Hong Kong

All Listed Sponsors
collaborator

North District Hospital

OTHER

collaborator

King Chulalongkorn Memorial Hospital

OTHER

collaborator

Changi General Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT02534571 - To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes | Biotech Hunter | Biotech Hunter